C
CRL icon

Covestor’s Charles River Laboratories CRL Stock Holding History

Covestor’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25K Buy
111
+3
+3% +$534 0.01% 1096
2026
Q1 		$18K Sell
108
-137
-56% -$25.4K 0.01% 1146
2025
Q4 		$49K Sell
245
-1
-0.4% -$181 0.03% 913
2025
Q3 		$38K Sell
246
-271
-52% -$43K 0.02% 1032
2025
Q2 		$78K Buy
517
+122
+31% +$16.3K 0.05% 685
2025
Q1 		$60K Sell
395
-43
-10% -$7.21K 0.04% 766
2024
Q4 		$81K Buy
438
+111
+34% +$21.4K 0.05% 639
2024
Q3 		$65K Buy
327
+95
+41% +$19.7K 0.04% 750
2024
Q2 		$48K Buy
232
+55
+31% +$12.5K 0.03% 875
2024
Q1 		$48K Sell
177
-35
-17% -$8.36K 0.03% 896
2023
Q4 		$50K Buy
212
+5
+2% +$983 0.03% 851
2023
Q3 		$41K Sell
207
-12
-5% -$2.46K 0.03% 852
2023
Q2 		$46K Buy
219
+158
+259% +$31.4K 0.04% 813
2023
Q1 		$12K Sell
61
-27
-31% -$6.12K 0.01% 1215
2022
Q4 		$19K Buy
88
+7
+9% +$1.53K 0.02% 1043
2022
Q3 		$16K Buy
81
+41
+103% +$8.85K 0.01% 1064
2022
Q2 		$9K Sell
40
-134
-77% -$32.7K 0.01% 1245
2022
Q1 		$49K Buy
174
+87
+100% +$26.8K 0.03% 809
2021
Q4 		$33K Buy
+87
New +$33.8K 0.05% 722

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Covestor's CRL Position: Q2 2026 in Review

Covestor increased its Charles River Laboratories (CRL) stake by 2.8% in Q2 2026, buying an estimated $534 and bringing the position to 111 shares worth $25K. The position accounts for 0.01% of the portfolio, ranked #1096.

Covestor first reported a position in CRL in Q4 2021 and has held it in 19 quarters since. The position peaked at $81K in Q4 2024. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Covestor held 111 shares of Charles River Laboratories worth $25K as of Q2 2026.
  • Covestor bought 3 Charles River Laboratories shares in Q2 2026, an estimated $534.
  • Charles River Laboratories made up 0.01% of Covestor's portfolio in Q2 2026, its #1096 holding.
  • Covestor first reported a position in Charles River Laboratories in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Charles River Laboratories position peaked at $81K in Q4 2024.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.